PPI vs H2 Blockers for GERD: 8 Key Differences to Choose the Right Acid Reducer

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

PPI vs H2 blockers for GERD — PPI vs H2 Blockers for GERD: 8 Key Differences to Choose the Right Acid Reducer. Read on for an evidence-backed guide covering everything you need to know.

Key Takeaways

• PPI vs H2 blockers for GERD isn’t about which is “better” — it’s about which matches your symptom pattern. PPIs provide deeper, longer-lasting acid suppression for daily reflux; H2 blockers work faster for intermittent symptoms, especially at night. One works within an hour; the other can take 4 days to reach full effect.
• The biggest difference most guides never mention: PPIs cause acid rebound hypersecretion when stopped abruptly. This affects up to 40% of long-term users and is the #1 reason people feel they “can’t live without” their PPI — when in reality, they’re experiencing withdrawal, not their original GERD.
• Long-term PPI use has been associated with modestly increased risks of kidney disease, bone fractures, C. difficile infection, and vitamin B12 deficiency. H2 blockers have a more favourable long-term safety profile for most of these outcomes — but one specific risk goes the other way.
• For nighttime GERD — which disrupts sleep and causes silent aspiration — H2 blockers are often more effective than PPIs alone. A specific combination approach can control nighttime symptoms when neither class works perfectly by itself.
• You can switch from a PPI to an H2 blocker safely — but how you make the switch matters more than the switch itself. Taper, don’t quit cold turkey. The tapering strategy that works in over 80% of patients is simpler than you probably expect.

PPI vs H2 blockers for GERD — if you’ve ever stood in the pharmacy aisle staring at omeprazole on one shelf and famotidine on another — or, more likely, if your doctor handed you a prescription months ago and you’ve been refilling it ever since without questioning whether it’s still the right choice — you’re not alone. An estimated 15-30% of adults in Western countries experience GERD symptoms weekly, and proton pump inhibitors like omeprazole, pantoprazole, and esomeprazole are among the most prescribed medications on the planet. Globally, PPI use has more than doubled in the past two decades.

PPI vs H2 blockers for GERD — but here’s what most people don’t realise: there’s an entire second class of acid-reducing medications — H2 receptor antagonists (H2 blockers) — that works through a completely different mechanism. And for a significant subset of GERD sufferers, an H2 blocker might actually be the better choice. The PPI vs H2 blockers for GERD decision isn’t one-size-fits-all, and the right answer depends on when your symptoms strike, how often, and what you’re trying to achieve long-term.

PPI vs H2 blockers for GERD — one number in particular — a statistic about how many long-term PPI users could successfully switch to an H2 blocker or reduce their dose — might make you reconsider the pill you take every morning.

What Are PPIs and H2 Blockers? — PPI vs H2 blockers for GERD Explained

Proton pump inhibitors (PPIs) are a class of medications that suppress stomach acid production by irreversibly blocking the hydrogen-potassium ATPase enzyme system — the “proton pump” — in the gastric parietal cells lining the stomach. Because the blockade is irreversible, the acid-suppressing effect lasts until the body synthesises new proton pumps, which takes approximately 24-48 hours.

PPI vs H2 blockers for GERD — common PPIs include omeprazole (Prilosec), esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid), and rabeprazole (Aciphex). They are available both over-the-counter (for short-term use, typically 14 days) and by prescription (for longer courses and higher doses).

Quick Answer: PPIs block the final step of acid production in stomach cells, providing deep, sustained acid suppression ideal for healing erosive esophagitis and controlling daily GERD. H2 blockers block the histamine signal that stimulates acid release, providing faster but shorter-lasting relief suited for intermittent or nighttime symptoms.

H2 receptor antagonists (H2 blockers) suppress acid production by blocking histamine H2 receptors on the same parietal cells. Histamine is one of three primary signals (along with gastrin and acetylcholine) that tell the stomach to produce acid. By blocking the histamine signal, H2 blockers reduce — but do not eliminate — acid secretion. The blockade is reversible, so the effect wears off as the medication is cleared from the body.

PPI vs H2 blockers for GERD — common H2 blockers include famotidine (Pepcid), cimetidine (Tagamet), and nizatidine. Ranitidine (Zantac) was withdrawn from the market in 2020 due to contamination with NDMA, a probable human carcinogen — newer formulations of ranitidine have been reformulated in some countries, but famotidine is now the dominant H2 blocker worldwide.

The critical difference in the PPI vs H2 blockers for GERD comparison is that PPIs block the pump itself (the final common pathway), while H2 blockers block only one of several signals that activate it. This is why PPIs provide more complete acid suppression — and also why they carry more long-term concerns.

How Do PPIs and H2 Blockers Work? — PPI vs H2 blockers for GERD Explained

PPI vs H2 blockers for GERD — imagine your stomach’s parietal cells as small factories that produce acid. Each factory has a production line that ends with a pump (the proton pump, or H+/K+ ATPase) that pushes acid into the stomach. Three different managers — histamine, gastrin, and acetylcholine — can each tell the pump to speed up production.

PPI vs H2 blockers for GERD — a proton pump inhibitor doesn’t fire any of the managers. It walks directly to the pump, disables it, and keeps it broken until the factory builds a new one. No matter how many signals the managers send, the broken pump can’t produce acid. This is why PPIs work regardless of what triggered the acid — food, stress, coffee, or an empty stomach. And because the pump stays broken for about 24 hours, a single morning dose provides all-day acid suppression.

PPI vs H2 blockers for GERD — an H2 blocker fires one of the three managers — the histamine manager. Without histamine signalling, acid production drops, but the remaining managers (gastrin and acetylcholine) can still activate some pumps. This is why H2 blockers reduce acid but don’t shut it down as completely as PPIs. And because the manager is only temporarily “fired” (the blockade is reversible), the effect lasts 4-12 hours rather than 24.

PPI vs H2 blockers for GERD — this mechanistic difference explains everything that follows: why PPIs take longer to work (they have to be absorbed, activated in the acidic environment of the parietal cell canaliculus, and then bind to active pumps — a process that takes hours to begin and days to reach steady state), why H2 blockers work faster (blocking a receptor is pharmacologically simpler than disabling a pump), and why the safety profiles diverge (sustained, near-total acid suppression vs intermittent, partial suppression have different physiological consequences over time).

PPI vs H2 Blockers for GERD: 8 Key Differences

1. Onset of action. H2 blockers begin reducing acid within 30-60 minutes of an oral dose. PPIs take 1-4 days of daily dosing to reach their full acid-suppressive effect. For immediate heartburn relief, an H2 blocker or antacid is the clear winner. For sustained daily control, the PPI’s slow build to steady state is acceptable — but you won’t feel the full benefit on day one.

2. Duration of effect. A single PPI dose suppresses acid for approximately 24 hours and sometimes longer, because new proton pumps must be synthesised to replace the irreversibly inhibited ones. H2 blockers typically provide 4-12 hours of acid suppression, with tolerance developing in some patients within 1-2 weeks of continuous use (a phenomenon called tachyphylaxis).

3. Degree of acid suppression. PPIs reduce gastric acid secretion by 80-95% — near-total suppression. H2 blockers reduce it by approximately 50-70%. For erosive esophagitis (where stomach acid has actually damaged the oesophageal lining), the deeper suppression from a PPI is usually necessary for healing. For non-erosive reflux or mild GERD, H2 blocker-level suppression may be sufficient.

4. Meal timing. PPIs work best when taken 30-60 minutes before a meal, because they only inhibit active pumps — and pumps become active when you eat. Taking a PPI with food or after a meal significantly reduces its effectiveness. H2 blockers can be taken with or without food and are less timing-dependent, though taking them before a meal that triggers symptoms provides the most targeted relief.

5. Healing erosive esophagitis. PPIs are superior for healing oesophageal erosions, with healing rates of approximately 80-90% at 8 weeks compared to 50-60% for H2 blockers. This is the one indication where the PPI vs H2 blockers for GERD decision has a clear evidence-based winner.

6. Nighttime acid control. H2 blockers are often more effective than PPIs for controlling nocturnal acid breakthrough — the midnight-to-4am window when even a morning PPI dose may not fully suppress acid. This is because overnight, the stimulants of acid production shift (less food-driven, more histamine-driven baseline secretion). Adding a bedtime H2 blocker to a morning PPI is a well-established strategy for refractory nighttime GERD.

7. Drug interactions. Omeprazole and esomeprazole inhibit the CYP2C19 liver enzyme, which metabolises clopidogrel (Plavix), citalopram, diazepam, and several other medications. Pantoprazole has minimal CYP2C19 interaction. Famotidine and other H2 blockers have fewer cytochrome P450 interactions overall, though cimetidine inhibits multiple CYP enzymes and has more drug interactions than other H2 blockers.

8. Cost and availability. Both classes are available as inexpensive generics. A month of generic omeprazole 20mg or famotidine 20mg costs approximately $5-15 without insurance. PPIs at prescription doses (40mg twice daily) cost more, and esomeprazole tends to be the most expensive generic PPI. Over-the-counter availability is comparable for both classes, though the OTC versions are typically lower-dose and labelled for short-term use only (14 days).

Speed of Relief: Which Works Faster?

When heartburn strikes and you need relief now, the PPI vs H2 blockers for GERD comparison has a straightforward answer: H2 blockers work faster. Much faster.

PPI vs H2 blockers for GERD — a single dose of famotidine 20mg begins reducing gastric acidity within 30-60 minutes, with peak effect at 1-3 hours. The effect lasts 6-12 hours in most people. This makes H2 blockers ideal for on-demand use — take one when you feel heartburn starting, or take one before a meal you know will trigger symptoms.

PPI vs H2 blockers for GERD — a PPI like omeprazole 20mg, by contrast, achieves only about 30-40% of its maximum acid-suppressive effect on day one. It takes approximately 3-4 days of consistent daily dosing to reach steady-state acid suppression of 80-95%. This is not a flaw in the medication — it’s a consequence of the mechanism. PPIs only inhibit pumps that are active at the time the drug is present in the bloodstream. Since not all pumps are active simultaneously, it takes several daily doses to accumulate enough inhibited pumps for full effect.

What this means for you: If your GERD is episodic — you get heartburn a couple of times a week, typically after specific meals or when you lie down too soon after eating — an on-demand H2 blocker is likely the more practical choice. You take it when you need it, it works within the hour, and you’re not committed to daily medication. If your GERD is daily — you wake up with heartburn, you have it regardless of what you eat, and it’s affecting your quality of life — the PPI’s slower onset is worth the wait for the deeper, sustained control it provides.

Long-Term Safety: What the Evidence Says

PPI vs H2 blockers for GERD — this is the section that matters most for anyone taking acid-reducing medication for months or years. The PPI vs H2 blockers for GERD safety comparison isn’t perfectly clean — both classes are generally safe — but long-term PPI use has attracted more scrutiny in the past decade. Here’s what the evidence actually shows:

PPI long-term risks (observational data — the evidence quality is mostly moderate, not high):

H2 blocker long-term risks:

PPI vs H2 blockers for GERD — the takeaway from this safety comparison is nuanced. For short-term use (weeks to a few months), both classes are very safe. For long-term use (years), H2 blockers appear to have a more favourable safety profile for most outcomes — but the clinical benefit of PPIs (superior healing of erosive esophagitis, better control of severe daily GERD, prevention of Barrett’s oesophagus progression) often outweighs these small absolute risks. The key is using the lowest effective dose for the shortest necessary duration — regardless of which class you take.

The Acid Rebound Effect: Why Stopping PPIs Feels Impossible

PPI vs H2 blockers for GERD — here’s the phenomenon that explains why so many people feel “addicted” to their PPI. It’s not psychological dependence — it’s a predictable physiological response called rebound acid hypersecretion (RAH).

PPI vs H2 blockers for GERD — when you take a PPI for more than about 4-8 weeks, your body adapts to the low-acid environment. Gastrin levels rise (the body’s attempt to stimulate acid production), and the number of proton pumps in parietal cells increases. When you suddenly stop the PPI, you now have more pumps than normal and higher gastrin driving them — and suddenly nothing is blocking them. The result: acid secretion temporarily overshoots baseline levels, often by 30-50% or more.

Research Spotlight: A double-blind, placebo-controlled study published in Gastroenterology demonstrated that healthy volunteers who took esomeprazole 40mg for 8 weeks and then stopped developed significant rebound acid hypersecretion lasting 2-4 weeks. During this period, they experienced more heartburn and dyspepsia than they had before starting the PPI — even though they had no underlying GERD. The study authors concluded that PPI withdrawal symptoms are a real pharmacological phenomenon, not a return of the original disease.

This is the trap: you start a PPI for legitimate GERD symptoms. You feel better. After a few months or years, you wonder if you still need it. You stop. Within days, you feel worse than you did before you ever started. You conclude your GERD must still be severe and resume the PPI. But what you experienced may have been primarily rebound, not your original reflux.

The PPI vs H2 blockers for GERD comparison matters here because H2 blockers can serve as a bridge during PPI tapering. By taking an H2 blocker on-demand during the rebound period (typically 2-4 weeks after stopping or reducing the PPI), you blunt the rebound symptoms while your body re-adjusts to normal acid production. The H2 blocker is then easier to stop than the PPI was, because H2 blockers cause less profound rebound when discontinued.

A simple tapering strategy that works for most people:

• Week 1: Reduce PPI dose by half (e.g., omeprazole 40mg 20mg daily)
• Week 2: Switch to alternate-day PPI dosing
• Week 3: Stop PPI; use H2 blocker (famotidine 10-20mg) on-demand for breakthrough symptoms
• Week 4: Reduce H2 blocker to as-needed only; most people need it 1-2 times per week or less

This approach allows successful PPI discontinuation or dose reduction in approximately 60-80% of chronic users according to clinical studies. Consult your doctor before making any changes to your medication regimen — this framework is for discussion with your healthcare provider, not a self-directed plan.

Nighttime GERD: When H2 Blockers Shine

Nighttime reflux deserves special attention because it’s not just uncomfortable — it’s more damaging than daytime reflux. When you’re upright during the day, gravity and swallowing help clear refluxed acid from your oesophagus. When you’re lying flat at night, acid pools in the oesophagus for extended periods, and the protective salivary bicarbonate that neutralises acid during the day is reduced during sleep.

Nighttime GERD is associated with:

• Sleep disruption and next-day fatigue
• Silent aspiration (stomach contents reaching the airways, contributing to chronic cough, laryngitis, and asthma)
• Higher risk of erosive esophagitis and Barrett’s oesophagus compared to daytime-only reflux
• Increased risk of oesophageal adenocarcinoma with long-standing nocturnal reflux

The PPI vs H2 blockers for GERD at night takes an interesting turn here. PPIs taken in the morning suppress daytime acid well but may not fully control the midnight-to-early-morning window because the drug has been metabolised and new pumps have been synthesised by then. This is called nocturnal acid breakthrough (NAB) and affects approximately 70% of patients on once-daily PPIs.

H2 blockers taken at bedtime are particularly effective at suppressing this nighttime acid surge because much of nocturnal acid secretion is histamine-driven (as opposed to food-driven daytime secretion). A bedtime dose of famotidine 20-40mg can often control NAB that a morning PPI misses.

For people with nighttime-predominant GERD, the evidence supports either:

• An H2 blocker alone at bedtime (for intermittent nighttime symptoms)
• A morning PPI plus a bedtime H2 blocker (for severe, daily GERD with prominent nighttime symptoms)
• A PPI taken twice daily (before breakfast and before dinner) rather than once daily

The bedtime PPI + H2 blocker combination is well-established in gastroenterology practice for refractory nighttime GERD, though tolerance to the H2 blocker component can develop after 1-2 weeks of continuous nightly use.

How to Choose Between a PPI and an H2 Blocker

The “better choice” here doesn’t mean the other class is wrong — it means the evidence leans in one direction for that specific scenario. In practice, many people use both: a PPI for daily control during flare-ups and an H2 blocker for breakthrough symptoms or as a step-down strategy.

MedsBase carries a complete range of acid reducer medications across both classes — if your doctor prescribes a PPI or recommends an H2 blocker, you can compare options, dosages, and prices in one place.

How to Switch from a PPI to an H2 Blocker Safely

If you’ve been on a PPI long-term and want to explore switching to an H2 blocker — either for safety concerns, cost reasons, or simply to see if you still need daily acid suppression — the key is tapering, not quitting abruptly. Here’s a step-by-step approach to discuss with your doctor:

Step 1 — Confirm the diagnosis. Before making any change, make sure you actually have GERD (and not, say, functional dyspepsia or eosinophilic esophagitis, which wouldn’t respond to acid suppression the same way). If your diagnosis was made years ago and you’ve been on PPIs ever since without re-evaluation, it may be time for a check-in with your doctor.

Step 2 — Reduce the PPI dose first, don’t switch cold. If you’re on omeprazole 40mg daily, drop to 20mg daily for 1-2 weeks. If on 20mg, try alternate-day dosing. The goal is to find the lowest PPI dose that still controls your symptoms before introducing the H2 blocker.

Step 3 — Introduce the H2 blocker as a bridge. On the days you don’t take the PPI, take famotidine 20mg at bedtime or before your most symptom-provoking meal. This blunts the rebound acid surge that occurs on PPI-off days.

Step 4 — Stop the PPI and assess. After 1-2 weeks of alternate-day PPI dosing, stop the PPI entirely and use the H2 blocker on-demand. Some people need it daily for the first week or two; most settle into an as-needed pattern (1-3 times per week) after 2-4 weeks.

Step 5 — Lifestyle optimisation. Use the H2 blocker as a tool, not a crutch. During the switch period, be especially diligent about: not eating within 3 hours of bedtime, elevating the head of your bed by 15-20cm, identifying and avoiding your personal trigger foods, reducing alcohol and caffeine, and losing weight if you’re overweight (the single most effective non-drug intervention for GERD).

Step 6 — Re-evaluate after 4 weeks. If your symptoms are well-controlled with occasional H2 blocker use, you’ve successfully switched. If you need daily H2 blocker use and it’s working, that’s also a reasonable outcome — famotidine 20-40mg daily has a favourable long-term safety profile. If your symptoms are uncontrolled despite daily H2 blocker use and lifestyle measures, returning to the lowest effective PPI dose is reasonable — some people genuinely need the deeper suppression PPIs provide, and there’s no shame in taking a medication that demonstrably improves your quality of life.

Related Reading

• Shingles Vaccine Cardiovascular Benefits: 7 Heart-Protective Effects — Chronic medication decisions, like managing GERD, often intersect with other aspects of health. Understanding how to protect your heart while managing other conditions is a natural next step.
• Community-Acquired MRSA Infection: Symptoms, Treatment, and Prevention Guide — Sometimes antibiotics for conditions like H. pylori (a common GERD-related concern) can upset the balance of bacteria your body carries. Understanding infection management rounds out your health knowledge.
• Blood Pressure Management: A Complete Guide — Many people managing GERD are also managing blood pressure — and some BP medications can affect reflux symptoms. Knowing your options across both areas helps you have more informed conversations with your doctor.

Frequently Asked Questions

Q: Which is better for GERD — PPI or H2 blocker?

A: Neither is universally “better” — the PPI vs H2 blockers for GERD decision depends on your specific symptom pattern. For severe, daily GERD with erosive esophagitis, PPIs provide more complete acid suppression and higher healing rates (80-90% vs 50-60% at 8 weeks). For intermittent, mild-to-moderate GERD occurring a few times per week, H2 blockers offer faster relief (within 1 hour vs 1-4 days for PPIs) with a more favourable long-term safety profile. For nighttime-predominant GERD, H2 blockers taken at bedtime are often more effective than a morning PPI alone.

Q: What is the safest acid reflux medication for long-term use?

A: For long-term daily use, H2 blockers — particularly famotidine — generally carry fewer long-term risks than PPIs. PPIs have been associated with modestly increased risks of kidney disease, bone fractures, C. difficile infection, and vitamin B12 deficiency with prolonged use, though absolute risks remain low. H2 blockers have fewer associations with these outcomes, but they do tend to become less effective with continuous daily use due to tolerance (tachyphylaxis), which limits their utility as a daily long-term monotherapy. The safest approach, regardless of medication class, is using the lowest effective dose for the shortest necessary duration.

Q: How long does it take for PPIs to work vs H2 blockers?

A: H2 blockers begin reducing acid within 30-60 minutes of a dose, with peak effect at 1-3 hours. PPIs take 1-4 days of daily dosing to reach their full therapeutic effect. This is a fundamental difference in the PPI vs H2 blockers for GERD comparison — H2 blockers are on-demand medications that work quickly, while PPIs are preventive medications that need consistent daily use to build and maintain their effect.

Q: Can I switch from a PPI to an H2 blocker?

A: Yes, and a significant percentage of long-term PPI users can successfully switch or reduce their dose. The key is tapering, not stopping abruptly. The recommended approach is: reduce your PPI dose for 1-2 weeks, transition to alternate-day PPI dosing for another 1-2 weeks while adding an H2 blocker on non-PPI days, then stop the PPI and use the H2 blocker on-demand. This strategy mitigates the rebound acid hypersecretion that makes abrupt PPI discontinuation so difficult. Always discuss any medication change with your doctor first.

Q: What happens when you stop taking PPIs?

A: Abruptly stopping a PPI after more than 4-8 weeks of use typically causes rebound acid hypersecretion — a temporary surge in stomach acid production that overshoots your pre-treatment baseline. This can cause heartburn and indigestion that feels worse than your original GERD, lasting 2-4 weeks. Many people interpret this as proof that they “need” the PPI when in reality they’re experiencing a predictable withdrawal phenomenon. Tapering the dose gradually — and using an H2 blocker as a bridge during the taper — dramatically reduces rebound symptoms.

Q: Can I take a PPI and an H2 blocker together?

A: Yes, and this combination is used clinically for specific situations. The most common scenario is a morning PPI for daytime acid control plus a bedtime H2 blocker for nocturnal acid breakthrough — nighttime acid secretion that a single morning PPI doesn’t fully suppress. The combination is generally safe, though there is a theoretical concern that H2 blockers taken shortly before a PPI could reduce the PPI’s effectiveness (PPIs need active pumps to work, and H2 blockers reduce pump activity). Spacing them apart — PPI in the morning before breakfast, H2 blocker at bedtime — avoids this interaction.

Q: Do H2 blockers cause dementia like some PPIs have been linked to?

A: Neither PPIs nor H2 blockers have been convincingly causally linked to dementia. Some observational studies have reported associations between PPI use and a small increased risk of dementia, but these studies are confounded by the fact that people who take PPIs long-term tend to have more comorbidities and take more medications overall. No mechanism has been established, and large, well-controlled studies have not consistently replicated the finding. H2 blockers have not been linked to dementia risk. Current expert consensus is that neither class requires discontinuation based on dementia concerns alone.

Q: Can I take an H2 blocker every day?

A: Yes, famotidine 20-40mg daily is approved for daily use and is generally well-tolerated. However, two considerations apply: (1) Tolerance (tachyphylaxis) can develop within 1-2 weeks of continuous daily use, reducing the medication’s effectiveness — this is why H2 blockers are often used on-demand rather than daily. (2) If you need daily acid suppression long-term and an H2 blocker isn’t providing adequate control, a PPI is the evidence-based next step. The PPI vs H2 blockers for GERD decision for daily users should be based on actual symptom control, not theoretical preferences.

The Bottom Line

The PPI vs H2 blockers for GERD comparison isn’t a contest with a single winner. It’s a framework for matching the right medication to the right symptom pattern — and for understanding that the “right” choice can change over time.

If your GERD is daily and erosive, a PPI gives you the best chance of healing and sustained relief. If your GERD is intermittent and predictable, an H2 blocker gives you faster relief with fewer long-term concerns. If your GERD keeps you awake at night, an H2 blocker at bedtime may work better than a PPI alone. And if you’ve been on a PPI for years and aren’t sure you still need it, the acid rebound effect — not your original disease — may be what’s keeping you on it.

Your next step: Review your current medication and symptom pattern honestly. Are you taking a PPI daily out of genuine need, or out of fear of the rebound that would follow if you stopped? Do your symptoms happen mainly at night, suggesting an H2 blocker might be more effective? Have you been on the same dose for years without re-evaluation? These are worth discussing at your next doctor’s visit — not as a self-directed medication change, but as an informed conversation.

What to read next: Chronic conditions rarely travel alone. If you’re managing GERD, there’s a good chance you’re managing other health priorities too. Our guide to blood pressure management covers medication options for another common chronic condition, and the shingles vaccine cardiovascular benefits guide explores a surprising layer of heart protection you may not have considered.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Never start, stop, or change your medication without consulting your doctor. GERD can have serious complications including erosive esophagitis, strictures, and Barrett’s oesophagus — proper diagnosis and management require professional medical evaluation. If you experience chest pain, especially if it radiates to your arm, jaw, or back, seek emergency medical attention — heart attack symptoms can mimic severe heartburn.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.